Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611442 · ClinicalTrials.gov registry record · NA
Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy
A NA study, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 191
- Enrollment target
NCT00611442 is a NA study that has completed, run by Brooke Army Medical Center. The registered enrollment target is 191 participants.
The verdict
NCT00611442, a NA study, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 191 participants
- Enrollment target
Study Summary
The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detected on examination.
Interventions
- DRUG placebo
- DRUG lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00611442
The ClinicalTrials.gov registry entry for NCT00611442 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00611442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00611442 about?
NCT00611442 is a clinical study titled "Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy". The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detect...
What is the current status of trial NCT00611442?
This trial is currently completed. It is a NA study. The enrollment target is 191 participants. The study started on 2007-10. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00611442?
The interventions under investigation include: placebo (DRUG), lubiprostone (DRUG).
Who is sponsoring clinical trial NCT00611442?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.